Last 12 months
Inside the activity.
7 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 7 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2026 Filed Aug 25, 2026 18:18 UTC |
Law Alan SiemsDirector · See Remarks
|
GiftCommon Stock | 40 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002088869-26-000001 · primary_doc.xml · nonDerivative · entry 2 Law Alan Siems · CIK 0002089168 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,961 F1 · kind: Each reported transaction represents a bona fide gift of 40 shares to a separate individual for no consideration. F1 · price: Each reported transaction represents a bona fide gift of 40 shares to a separate individual for no consideration. Read SEC document |
| August 25, 2026 Filed Aug 25, 2026 18:18 UTC |
Law Alan SiemsDirector · See Remarks
|
GiftCommon Stock | 40 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002088869-26-000001 · primary_doc.xml · nonDerivative · entry 1 Law Alan Siems · CIK 0002089168 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,001 F1 · kind: Each reported transaction represents a bona fide gift of 40 shares to a separate individual for no consideration. F1 · price: Each reported transaction represents a bona fide gift of 40 shares to a separate individual for no consideration. Read SEC document |
| June 15, 2026 Filed Jun 22, 2026 12:16 UTC |
SWENSON PETER GDirector · CEO and Chairman
|
GrantRestricted Stock Units · Derivative | 23,785 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-076104 · tm2618421-6_4seq1.xml · derivative · entry 1 SWENSON PETER G · CIK 0001234991 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,785 Underlying: Common Stock · 23,785 shares Expires not disclosed F1 · security: Each restricted stock unit represents a contingent right to receive one share of Park Dental Partners, Inc. Common Stock upon vesting. F2 · security: The restricted stock units vest 25% on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date and the terms of the applicable award agreement. F3 · security: The restricted stock units were granted for no cash consideration. F2 · derivative.exercise_date: The restricted stock units vest 25% on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date and the terms of the applicable award agreement. F2 · derivative.expiration_date: The restricted stock units vest 25% on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date and the terms of the applicable award agreement. Read SEC document |
| June 15, 2026 Filed Jun 22, 2026 12:17 UTC |
SMITH PHILIP IRVINGDirector
|
GrantRestricted Stock Units · Derivative | 2,632 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-076105 · tm2618421-7_4seq1.xml · derivative · entry 1 SMITH PHILIP IRVING · CIK 0001235464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,632 Underlying: Common Stock · 2,632 shares Expires not disclosed F1 · security: Each restricted stock unit represents a contingent right to receive one share of Park Dental Partners, Inc. Common Stock upon vesting. F2 · security: The restricted stock units vest in full on the first anniversary of the grant date, subject to the Reporting Person's continued service as a director through such date and the terms of the applicable award agreement. F3 · security: The restricted stock units were granted for no cash consideration. F2 · derivative.exercise_date: The restricted stock units vest in full on the first anniversary of the grant date, subject to the Reporting Person's continued service as a director through such date and the terms of the applicable award agreement. F2 · derivative.expiration_date: The restricted stock units vest in full on the first anniversary of the grant date, subject to the Reporting Person's continued service as a director through such date and the terms of the applicable award agreement. Read SEC document |
| June 15, 2026 Filed Jun 22, 2026 12:14 UTC |
Schaefer Anna MarieDirector
|
GrantRestricted Stock Units · Derivative | 2,632 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-076100 · tm2618421-2_4seq.xml · derivative · entry 1 Schaefer Anna Marie · CIK 0001360540 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,632 Underlying: Common Stock · 2,632 shares Expires not disclosed F1 · security: Each restricted stock unit represents a contingent right to receive one share of Park Dental Partners, Inc. Common Stock upon vesting. F2 · security: The restricted stock units vest in full on the first anniversary of the grant date, subject to the Reporting Person's continued service as a director through such date and the terms of the applicable award agreement. F3 · security: The restricted stock units were granted for no cash consideration. F2 · derivative.exercise_date: The restricted stock units vest in full on the first anniversary of the grant date, subject to the Reporting Person's continued service as a director through such date and the terms of the applicable award agreement. F2 · derivative.expiration_date: The restricted stock units vest in full on the first anniversary of the grant date, subject to the Reporting Person's continued service as a director through such date and the terms of the applicable award agreement. Read SEC document |
| June 15, 2026 Filed Jun 22, 2026 12:15 UTC |
Steele Christopher EugeneDirector · See Remarks
|
GrantRestricted Stock Units · Derivative | 5,855 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-076103 · tm2618421-5_4seq1.xml · derivative · entry 1 Steele Christopher Eugene · CIK 0002089998 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,855 Underlying: Common Stock · 5,855 shares Expires not disclosed F1 · security: Each restricted stock unit represents a contingent right to receive one share of Park Dental Partners, Inc. Common Stock upon vesting. F2 · security: The restricted stock units vest 25% on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date and the terms of the applicable award agreement. F3 · security: The restricted stock units were granted for no cash consideration. F2 · derivative.exercise_date: The restricted stock units vest 25% on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date and the terms of the applicable award agreement. F2 · derivative.expiration_date: The restricted stock units vest 25% on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date and the terms of the applicable award agreement. Read SEC document |
| June 15, 2026 Filed Jun 22, 2026 12:15 UTC |
Smith Christopher CharlesDirector
|
GrantRestricted Stock Units · Derivative | 2,632 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-076102 · tm2618421-4_4seq1.xml · derivative · entry 1 Smith Christopher Charles · CIK 0002089136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,632 Underlying: Common Stock · 2,632 shares Expires not disclosed F1 · security: Each restricted stock unit represents a contingent right to receive one share of Park Dental Partners, Inc. Common Stock upon vesting. F2 · security: The restricted stock units vest in full on the first anniversary of the grant date, subject to the Reporting Person's continued service as a director through such date and the terms of the applicable award agreement. F3 · security: The restricted stock units were granted for no cash consideration. F2 · derivative.exercise_date: The restricted stock units vest in full on the first anniversary of the grant date, subject to the Reporting Person's continued service as a director through such date and the terms of the applicable award agreement. F2 · derivative.expiration_date: The restricted stock units vest in full on the first anniversary of the grant date, subject to the Reporting Person's continued service as a director through such date and the terms of the applicable award agreement. Read SEC document |
| June 15, 2026 Filed Jun 22, 2026 12:14 UTC |
Bernander Christopher JamesDirector · Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 11,184 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-076101 · tm2618421-3_4seq1.xml · derivative · entry 1 Bernander Christopher James · CIK 0002089730 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,184 Underlying: Common Stock · 11,184 shares Expires not disclosed F1 · security: Each restricted stock unit represents a contingent right to receive one share of Park Dental Partners, Inc. Common Stock upon vesting. F2 · security: The restricted stock units vest 25% on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date and the terms of the applicable award agreement. F3 · security: The restricted stock units were granted for no cash consideration. F2 · derivative.exercise_date: The restricted stock units vest 25% on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date and the terms of the applicable award agreement. F2 · derivative.expiration_date: The restricted stock units vest 25% on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date and the terms of the applicable award agreement. Read SEC document |
| June 15, 2026 Filed Jun 22, 2026 12:12 UTC |
Law Alan SiemsDirector · See Remarks
|
GrantRestricted Stock Units · Derivative | 7,796 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-076099 · tm2618421-1_4seq1.xml · derivative · entry 1 Law Alan Siems · CIK 0002089168 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,796 Underlying: Common Stock · 7,796 shares Expires not disclosed F1 · security: Each restricted stock unit represents a contingent right to receive one share of Park Dental Partners, Inc. Common Stock upon vesting. F2 · security: The restricted stock units vest 25% on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date and the terms of the applicable award agreement. F3 · security: The restricted stock units were granted for no cash consideration. F2 · derivative.exercise_date: The restricted stock units vest 25% on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date and the terms of the applicable award agreement. F2 · derivative.expiration_date: The restricted stock units vest 25% on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date and the terms of the applicable award agreement. Read SEC document |
| December 03, 2025 Filed Dec 3, 2025 22:13 UTC |
SWENSON PETER GDirector · CEO and Chairman
|
PurchaseCommon Stock | 3,846 | $13.00 | $49,998.00 |
DisclosureSEC source: 0002088869-25-000017 · primary_doc.xml · nonDerivative · entry 1 SWENSON PETER G · CIK 0001234991 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,058 F1 · security: Reflects shares purchased pursuant to the Park Dental Partners, Inc. Directed Share Program. Read SEC document |
| December 03, 2025 Filed Dec 3, 2025 22:31 UTC |
SMITH PHILIP IRVINGDirector
|
PurchaseCommon Stock | 769 | $13.00 | $9,997.00 |
DisclosureSEC source: 0002088869-25-000021 · primary_doc.xml · nonDerivative · entry 1 SMITH PHILIP IRVING · CIK 0001235464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,569 F1 · security: Reflects shares purchased pursuant to the Park Dental Partners, Inc. Directed Share Program. Read SEC document |
| December 03, 2025 Filed Dec 3, 2025 22:37 UTC |
Smith Christopher CharlesDirector
|
PurchaseCommon Stock | 7,692 | $13.00 | $99,996.00 |
DisclosureSEC source: 0002088869-25-000022 · primary_doc.xml · nonDerivative · entry 1 Smith Christopher Charles · CIK 0002089136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,492 F1 · security: Reflects shares purchased pursuant to the Park Dental Partners, Inc. Directed Share Program. Read SEC document |
| December 03, 2025 Filed Dec 3, 2025 22:29 UTC |
Law Alan SiemsDirector
|
PurchaseCommon Stock | 1,923 | $13.00 | $24,999.00 |
DisclosureSEC source: 0002088869-25-000020 · primary_doc.xml · nonDerivative · entry 1 Law Alan Siems · CIK 0002089168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,041 F1 · security: Reflects shares purchased pursuant to the Park Dental Partners, Inc. Directed Share Program. Read SEC document |
| December 03, 2025 Filed Dec 3, 2025 22:26 UTC |
Gerlach Todd ChristopherDirector
|
PurchaseCommon Stock | 7,692 | $13.00 | $99,996.00 |
DisclosureSEC source: 0002088869-25-000019 · primary_doc.xml · nonDerivative · entry 1 Gerlach Todd Christopher · CIK 0002088553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,847 F1 · security: Reflects shares purchased pursuant to the Park Dental Partners, Inc. Directed Share Program. Read SEC document |
| December 03, 2025 Filed Dec 3, 2025 22:23 UTC |
Bernander Christopher JamesDirector · Chief Financial Officer
|
PurchaseCommon Stock | 1,923 | $13.00 | $24,999.00 |
DisclosureSEC source: 0002088869-25-000018 · primary_doc.xml · nonDerivative · entry 1 Bernander Christopher James · CIK 0002089730 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,756 F1 · security: Reflects shares purchased pursuant to the Park Dental Partners, Inc. Directed Share Program. Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 16:00 UTC Amendment |
SWENSON PETER GDirector · CEO and Chairman
|
PurchaseCommon Stock | 3,169 | $13.00 | $41,197.00 |
DisclosureSEC source: 0002088869-25-000023 · primary_doc.xml · nonDerivative · entry 1 SWENSON PETER G · CIK 0001234991 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,381 F1 · shares: The original Form 4, filed on December 3, 2025, is being amended by this Form 4 amendment solely to correct an administrative error based on incorrect preliminary information received, which misreported a prospective purchase that occurred on December 3, 2025 as a total of 3,846 shares purchased when in fact 3,169 shares of the Issuer's common stock were purchased. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.